Cite
HARVARD Citation
Semerano, L. et al. (n.d.). Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels. Clinical and experimental immunology. pp. 54-62. [Online].